Find uplifting stories about heroes, innovations, and solutions
17131 results for "johns hopkins research"
Two Johns Hopkins doctoral students just received prestigious scholarships to advance critical cancer research. Their work could help unlock new treatments and understand why some cancers affect certain groups more than others.
Tim Evans, diagnosed with ALS in 2014, chose to become the first volunteer in groundbreaking research at Johns Hopkins Medicine instead of letting his disease define his final chapter. His decision could help improve quality of life for thousands of ALS patients diagnosed each year.
Johns Hopkins University just launched "job family reunions" to help over 200 employees discover new career paths without leaving the institution. The first event connected staff across administrative, research, and human resources roles with mentors and career development resources.
Scientists at Johns Hopkins developed a nose-delivered vaccine that helps the body fight tuberculosis, the world's deadliest infectious disease. Early tests show it could shorten treatment times and prevent drug-resistant strains.
Scientists at Johns Hopkins Medicine have developed a new way to deliver healing therapy directly to the uterine lining, restoring fertility in mice with damaged tissue. The breakthrough offers hope for people struggling with infertility who haven't found success with current treatments.
A team of researchers across five countries just received $24 million to find a cure for hepatitis B, a virus that affects 300 million people worldwide. The five-year effort could finally bring hope to millions living with a disease that currently has no cure.
Matthew Hartshorn didn't just compete at the NCAA Championships—he shattered his own school record and claimed his third All-America honor. The senior's performance marked a historic moment for Johns Hopkins swimming.
Scientists at Johns Hopkins Medicine developed a magnetic imaging technique that lets them watch therapeutic cells travel through the body, potentially revolutionizing how doctors personalize cancer and autoimmune treatments. The breakthrough could help ensure every patient gets exactly the right dose delivered to the right place.
A new stem cell transplant developed at Johns Hopkins has cured sickle cell disease in 95% of patients, using half-matched donors like parents or siblings. The breakthrough means nearly every sickle cell patient can now access a cure that also preserves fertility.
A Johns Hopkins senior just became only the third fencer in school history to reach 300 career wins, leading her team to second place at nationals. The Blue Jays also captured their first sabre team championship in five years.
A team of scientists across five countries just received $24 million to pursue something 300 million people are waiting for: a cure for hepatitis B. The five-year project brings together researchers from Brazil, India, Senegal, Uganda, and the United States to turn laboratory discoveries into real treatments.
As Johns Hopkins celebrates its 150th anniversary, the institution now supports one in every five jobs in Baltimore and delivers a staggering $19.4 billion annual economic impact to the city. The university and health system have spent over $1 billion with local businesses since 2015, transforming how anchor institutions invest in their communities.
Penn State's men's lacrosse team delivered a stunning 16-8 upset victory over top-seeded Johns Hopkins to claim their second Big Ten Tournament championship. The Nittany Lions dominated the same stadium where they last won the conference title in 2019.
Johns Hopkins researchers discovered how vitamin A and thyroid hormones help babies develop sharp central vision before birth, overturning a 30-year-old theory. The breakthrough could lead to new treatments for macular degeneration and other blinding diseases.
New research from Johns Hopkins reveals that infants aren't as oblivious as they seem. Their minds are actively processing complex information about safety and risk from a surprisingly young age.
A hormone already used to treat osteoporosis might reverse chronic back pain by stopping nerves from growing into damaged spine areas. Johns Hopkins researchers discovered the treatment repairs deteriorating spinal tissue at its source.
A common lupus medication may protect patients with a skin form of the disease from heart complications and diabetes. Johns Hopkins researchers found the drug reduced cardiovascular risks significantly over five years.
A man diagnosed with ALS on Valentine's Day 2014 chose to become the first volunteer in a Johns Hopkins study aimed at improving quality of life for others with the disease. Instead of waiting at home, Tim Evans is dedicating his remaining time to advancing research that could help thousands.
Leading autism researchers and advocates formed a new independent committee to guide autism research priorities and counter recent federal changes. The group aims to unite the autism community and protect evidence-based research as funding reaches $568 million annually.
A scientist who revolutionized protein research is now tackling science's reproducibility crisis with AI. His new approach could help researchers separate reliable studies from questionable ones, speeding up cures for diseases like Alzheimer's.
Showing 20 of 17131